Evidence map›Paper›PMID 42602766›Full record

ArticlePlastic and reconstructive surgery. Global open2026

Enhancing Regenerative Outcomes: Histological Comparison of Hydroxyapatite-Carboxymethylcellulose Combined With Saline vs Platelet-rich Fibrin: A 21-day Study.

Julián Hernández, Natalia Ruiz, Brian Ramírez, Rafael Parra-Medina, Andreina Martínez, Agustina Varela

Abstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Julián HernándezFrom the PPlastic Surgery Private Practice, ARTI Clinic, Cali, Colombia.
Natalia RuizAesthetic and Antiaging Medicine Private Practice, ARTI Clinic, Cali, Colombia.
Brian RamírezPrivate Practice Aerospace Medicine, Bogota, Colombia.
Rafael Parra-MedinaPrivate Practice Pathology, Bogota, Colombia.
Andreina MartínezAesthetic Medicine Private Practice, Bogota, Colombia.
Agustina VarelaBiotechnology and Bioinformatics Department, Research Inc, Bogota, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Calcium hydroxyapatite-carboxymethylcellulose (CaHA-CMC) is a widely used biostimulatory agent that promotes collagen production and tissue remodeling. Platelet-rich fibrin (PRF), rich in growth factors, may enhance this biological response. This study evaluates the subdermal histopathological changes induced by saline solution (SS), PRF, CaHA-CMC + SS, and CaHA-CMC + PRF, with emphasis on early extracellular matrix remodeling and cellular response. Methods: A prospective study was conducted in 5 patients undergoing subdermal injections of the 4 study groups. Tissue samples were obtained at 21 days postinjection. Hematoxylin and eosin staining was analyzed using a semiquantitative digital histomorphometric surrogate (collagen-associated eosinophilic area). Immunohistochemical analysis for CD45 and collagen (types I, III, and IV) was performed in CaHA-containing groups. Statistical comparisons were conducted using the Wilcoxon signed-rank test. Results: CaHA-CMC + PRF demonstrated a significantly higher collagen-associated eosinophilic area compared to the saline control (3.07 times more; 95% CI: 2.10-4.20; Conclusions: The addition of PRF to CaHA-CMC appears to potentiate early subdermal tissue remodeling and cellular response. These findings suggest a synergistic biological effect; however, larger studies are required to confirm long-term clinical implications.

Identifiers

PMID42602766
PMCPMC13475926

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.